Non-invasive monitoring of inflammatory bowel disease using intestinal ultrasound

PMID: 40125503
Source: World J Gastrointest Endosc
Publication date: 2025-03-24
Year: 2025

Abstract

BACKGROUND: Intestinal ultrasound (IUS) is a safe and effective way for the diagnosis and surveillance of patients with inflammatory bowel disease (IBD). It allows a noninvasive and reproducible follow-up for patients with IBD. AIM: To compare the outcomes of colonoscopy and IUS in diagnosing and monitoring patients with IBD. METHODS: A prospective study was conducted over a three-year period (January 2021 to April 2024) comparing endoscopic and IUS findings. A total of 101 patients were included in the study (68 with Crohn's disease and 33 with ulcerative colitis). All patients underwent both IUS and colonoscopy within a 10-day period. RESULTS: The study found a strong correlation between bowel thickening on IUS and inflammatory activity (P = 0.004), IUS remission and endoscopic remission (P = 0.03), IUS and endoscopic location (P = 0.04), as well as IUS and computed tomography scan findings for collection diagnosis (P < 0.01). CONCLUSION: The study's findings demonstrated excellent results for using IUS in the diagnosis and follow-up of IBD patients.